Rheumatoid arthritis

Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

The study highlights the importance of understanding the heterogeneous nature of RA and its impact on patient outcomes.

Study context

Population
Rheumatoid arthritis (RA) patients in the FRANK registry
Participants
3,619 patients
Exposure
Five patient clusters based on age, physician's global assessment (PhGA), patient's pain assessment (PtPA) and Steinbrocker stage
  • Cluster 1n = 1,195
  • Cluster 2n = 641
  • Cluster 3n = 1,117
  • Cluster 4n = 385
  • Cluster 5n = 281
Outcome
Functional status (mHAQ)
Methodological detailsregistry-based, hierarchical and k-means cluster analyses
  • Registry-based
  • Hierarchical and k-means cluster analyses

Main finding

As reported in the abstract

Cluster 1

0.18

SD 0.30

Cluster 2

0.15

SD 0.26

Cluster 5

0.87

SD 0.65

Observational data: associations, not effects.

Further findings

OutcomeValues
Satisfaction with treatment efficacy (1: very satisfied to 6: very unsatisfied)Cluster 1 1.9 (SD 0.7) · Cluster 2 2.0 (SD 0.7) · Cluster 5 2.9 (SD 0.9)
Steinbrocker stage III-IVDespite controlled inflammationCluster 3 95.4%
Disease activity, Cluster 4 (PhGA vs PtPA)Value is mean PhGACluster 4 mean 0.9 (SD 0.5) · mean PtPA 5.0±2.1
Quality of life (EQ5D)Cluster 5 0.60 (SD 0.17)

Satisfaction with treatment efficacy (1: very satisfied to 6: very unsatisfied)

Cluster 4: more pronounced negative effect on satisfaction

Original publication

Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry. Clin Exp Rheumatol. Published 16 June 2024. doi:10.55563/clinexprheumatol/7emd6z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.